DÄ internationalArchive48/2006Intensity Modulated Radiotherapy – a New Option for Tumor Treatment

Review article

Intensity Modulated Radiotherapy – a New Option for Tumor Treatment

Dtsch Arztebl 2006; 103(48): A-3268

Thilmann, C; Oelfke, U; Huber, P; Debus, J

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Mell LK, Roeske JC, Mundt AJ: A survey of intensity-modulated radiation therapy use in the United States. Cancer 2003; 98: 204–11. MEDLINE
2. Nilsson S, Norlen BJ, Widmark A: A systematic overview of radiation therapy effects in prostate cancer. Acta Oncol 2004; 43: 316–81. MEDLINE
3. Jackson A, Skwarchuk MW, Zelefsky MJ et al.: Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 2001; 49: 685–98. MEDLINE
4. Zelefsky MJ, Fuks Z, Happersett L et al.: Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000; 55: 241–9. MEDLINE
5. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA: Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999; 45: 577–87. MEDLINE
6. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A: Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 2003; 57: 61–70. MEDLINE
7. Eisbruch A, Marsh LH, Dawson LA et al.: Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004; 59: 28–42. MEDLINE
8. Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA: Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003; 55: 312–21. MEDLINE
9. Lee N, Xia P, Quivey JM et al.: Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002; 53: 12–22. MEDLINE
10. Yao M, Dornfeld KJ, Buatti JM et al.: Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma-the University of Iowa experience. Int J Radiat Oncol Biol Phys 2005; 63: 410–21. MEDLINE
11. Wolden SL, Chen WC, Pfister DG et al.: Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-kettering experience. Int J Radiat Oncol Biol Phys 2006. MEDLINE
12. Munter MW, Thilmann C, Hof H et al.: Stereotactic intensity modulated radiation therapy and inverse treatment planning for tumors of the head and neck region: clinical implementation of the step and shoot approach and first clinical results. Radiother Oncol 2003; 66: 313–21. MEDLINE
13. Debus J, Schulz-Ertner D, Schad L et al.: Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys 2000; 47: 591–6. MEDLINE
14. Schulz-Ertner D, Didinger B, Nikoghosyan A et al.: Optimization of radiation therapy for locally advanced adenoid cystic carcinomas with infiltration of the skull base using photon intensity-modulated radiation therapy (IMRT) and a carbon ion boost. Strahlenther Onkol 2003; 179: 345–51. MEDLINE
15. Thilmann C, Schulz-Ertner D, Unterberg A, Wannenmacher M, Debus J: Stereotaktische Strahlenbehandlung schädelbasisnaher Meningeome und Schwannome. Dtsch Arztebl 2004; 101(15): A 1022–26. VOLLTEXT
16. Zabel A, Thilmann C, Zuna I et al.: Comparison of forward planned conformal radiation therapy and inverse planned intensity modulated radiation therapy for esthesioneuroblastoma. Br J Radiol 2002; 75: 356–61. MEDLINE
17. Duthoy W, Boterberg T, Claus F et al.: Postoperative intensity-modulated radiotherapy in sinonasal carcinoma: clinical results in 39 patients. Cancer 2005; 104: 71–82. MEDLINE
18. Gupta V, Mychalczak B, Krug L et al.: Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2005; 63: 1045–52. MEDLINE
19. Milker-Zabel S, Zabel A, Thilmann C, Schlegel W, Wannenmacher M, Debus J: Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2003; 55: 162–7. MEDLINE
20. Bijl HP, van Luijk P, Coppes RP et al.: Unexpected changes of rat cervical spinal cord tolerance caused by inhomogeneous dose distributions. Int J Radiat Oncol Biol Phys 2003; 57: 274–81. MEDLINE
21. Sterzing F, Munter MW, Schafer M et al.: Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy. Strahlenther Onkol 2005; 181: 42–8. MEDLINE
22. Followill D, Geis P, Boyer A: Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. Int J Radiat Oncol Biol Phys 1997; 38: 667–72. MEDLINE
23. International Commission on Radiological Protection. ICRP Publication 60. In: Annals of the ICRP. Oxford: Pergamon 1991.
24. Kry SF, Salehpour M, Followill DS et al.: The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005; 62: 1195–203. MEDLINE

Info

Specialities